dapagliflozin

The drug comes in two strengths ZUCAPRIDE–M 500 priced at Rs12.80 per tablet and ZUCAPRIDE–M 1000 at Rs 14.80

Approximately 55 per cent of type T2D patients suffer from cardiovascular disease (CVD), which often leads to further…

The drug, on top of standard of care, reduced the composite measure of worsening of renal function or risk of cardiovascular (CV)…

The approval is for the strength of 10 mg/5 mg tablets

Glenmark will manufacture and supply Remogliflozin while Torrent will market the drug under its own trademark 'Zucator' in India…

Under the agreement, Sun Pharma will promote and distribute dapagliflozin under the brand name 'Oxra'